Friday, 10 July 2026
  
Login

Australia's most trusted
source of pharma news

Friday, 10 July 2026
News

Lilly, patient group invest $680K

Posted 9 July 2026 PM

Eli Lilly Australia and Diabetes Australia have joined forces, investing $680,000 in Menzies School of Health Research to expand digital health solutions for complex care in the Northern Territory.

The joint grant, which includes a $430,000 contribution from Lilly, will enable Menzies to expand its innovative work to address leading health complications for Territorians, including diabetes, cardiovascular and kidney disease.

To see the whole article, please login


Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (2)

Sales & Customer Relations (24)

Access & Reimbursement (1)

Clinical & Medical, R&D (6)

Regulatory, Pharmacovigilance & QA (4)

Other (11)

MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.